IMvigor130 clinical trial in patients (pts) with metastatic urothelial carcinoma (mUC): Analysis of upper tract (UT) and lower tract (LT) subgroups

dc.contributor.authorDe Santis, Maria
dc.contributor.authorGrande, Enrique
dc.contributor.authorMencinger, Marina
dc.contributor.authorLi, Jian-Ri
dc.contributor.authorPuente, Javier
dc.contributor.authorIzumi, Kouji
dc.contributor.authorLee, Jae-Lyun
dc.contributor.authorKose, Fatih
dc.contributor.authorAntonyan, Igor
dc.contributor.authorDing, Beiying
dc.contributor.authorPatel, Himika
dc.contributor.authorDavis, Ian D.
dc.date.accessioned2021-06-17T07:56:48Z
dc.date.available2021-06-17T07:56:48Z
dc.date.issued2020
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.issn0732-183Xen_US
dc.identifier.issue6en_US
dc.identifier.urihttp://hdl.handle.net/11727/6091
dc.identifier.volume38en_US
dc.identifier.wos000529525900577en_US
dc.language.isoengen_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleIMvigor130 clinical trial in patients (pts) with metastatic urothelial carcinoma (mUC): Analysis of upper tract (UT) and lower tract (LT) subgroupsen_US
dc.typeConference Objecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: